GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biocorp Production SA (FRA:8BP) » Definitions » Earnings per Share (Diluted)

Biocorp Production (FRA:8BP) Earnings per Share (Diluted) : €-0.15 (TTM As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Biocorp Production Earnings per Share (Diluted)?

Biocorp Production's Earnings per Share (Diluted) for the six months ended in Dec. 2022 was €0.38. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.15.

Biocorp Production's EPS (Basic) for the six months ended in Dec. 2022 was €0.38. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.15.

Biocorp Production's EPS without NRI for the six months ended in Dec. 2022 was €0.43. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.14.

During the past 12 months, Biocorp Production's average EPS without NRIGrowth Rate was -318.60% per year.

During the past 11 years, Biocorp Production's highest 3-Year average EPS without NRI Growth Rate was 39.80% per year. The lowest was -100.80% per year. And the median was -19.60% per year.


Biocorp Production Earnings per Share (Diluted) Historical Data

The historical data trend for Biocorp Production's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocorp Production Earnings per Share (Diluted) Chart

Biocorp Production Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.32 0.23 -0.29 0.07 -0.15

Biocorp Production Semi-Annual Data
Dec12 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.28 0.35 -0.53 0.38

Competitive Comparison of Biocorp Production's Earnings per Share (Diluted)

For the Medical Devices subindustry, Biocorp Production's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocorp Production's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biocorp Production's PE Ratio distribution charts can be found below:

* The bar in red indicates where Biocorp Production's PE Ratio falls into.



Biocorp Production Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Biocorp Production's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2022 is calculated as

Diluted Earnings Per Share (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.651-0)/4.399
=-0.15

Biocorp Production's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2022 is calculated as

Diluted Earnings Per Share (Q: Dec. 2022 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(1.663-0)/4.399
=0.38

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Biocorp Production  (FRA:8BP) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Biocorp Production Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Biocorp Production's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocorp Production (FRA:8BP) Business Description

Traded in Other Exchanges
N/A
Address
Technological Park Lavaur la Bechade, Issoire, FRA, 63500
Biocorp Production SA is engaged in the development, production, and marketing of medical devices and drug delivery systems for the pharmaceutical industry.

Biocorp Production (FRA:8BP) Headlines

No Headlines